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LABORATORY INVESTIGATION
Role of iron in the tubulo-interstitial injury in nephrotoxic
serum nephritis
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Role of iron in the tubulo-interstitial injury in nephrotoxic serum
nephritis. We studied the possibility that tubule fluid iron could be
involved in the pathogenesis of the tubulo-interstitial injury associated
with primary glomerular disease. Tubule fluid iron is determined by the
magnitude of the glomerular leak for transferrin and the iron saturation
of transferrin. To minimize tubule fluid iron in an experimental model of
glomerulonephritis, iron deficiency was induced in rats prior to the
induction of nephrotoxic serum nephritis. Iron deficiency did not effect
the development of glomerular disease as determined by proteinuria,
but had a marked effect on preventing the development of tubulo-
interstitial disease and renal functional deterioration. There was also a
strong correlation between the amount of functional deterioration and
extent of tubulo-interstitial disease and urinary iron excretion in both
the control and iron deficient animals. It is proposed that injury results
from iron being dissociated from transferrin at the more acid pH of the
tubule fluid. Iron, a transition element, is able to catalyze the Haber-
Weiss reaction with the formation of free hydroxyl radicals which
causes renal tubule cell injury, This tubulo-interstitial injury is the
major determinate of progressive renal functional deterioration in this
experimental model of glomerulonephritis.
There are two types of experimental renal disease that
commonly cause extensive tubulo-interstitial disease and prog-
ress to end stage disease, the remnant kidney [1] and nephro-
toxic serum nephritis (NSN) [2]. The remnant kidney is a
hypertensive model and it is felt that glomerular hypertension
resulting from systemic hypertension causes glomerular injury
which produces the tubulo-interstitial disease and renal failure
[3]. This is supported by the fact that conditions which increase
systemic pressure accelerates the renal disease [4] whereas
factors which reduce the systemic pressure are protective [5, 6].
This is further supported by the finding that renal ablation with
hyperfiltration but without hypertension does not cause pro-
gressive renal damage [7].
In contrast, nephrotoxic serum nephritis is a normotensive
disease which also progresses to end stage disease [8—10]. Thus,
the hemodynamic events which lead to end-stage renal disease
in the remnant kidney can not be evoked in the pathogenesis of
the progressive destruction in nephrotoxic serum nephritis.
Furthermore, in nephrotoxic serum nephritis [2], as with a
number of human renal diseases [11, 12], change in renal
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function more closely correlates with tubulo-interstitial disease
than glomerular disease. However, the mechanism by which
interstitial disease results from glomerular injury is unknown.
Because of the close association between proteinuria and
tubulo-interstitial disease, it has been suggested that proteinuria
mediates this injury. However, the suggested mechanisms by
which proteinuria could induce tubulo-interstitial disease are
not totally convincing. These include excess absorption of
protein by the proximal tubule cells with cellular damage from
protein overload and leakage of lysosomal enzymes into the
tubule lumen [13]. Another suggested cause is the formation of
intraluminal protein casts which leads to the obstruction of the
tubule and disruption of the tubule membrane with Tamm-
Horsfall protein released into the interstitium [14]. This could
result in an immune complex tubulo-interstitial nephntis medi-
ated by auto-antibodies to Tamm-Horsfall protein [14].
That a number of experimental, as well as human, proteinuric
renal diseases are not accompanied by severe tubulo-interstitial
disease perhaps disputes the idea that proteinuria causes tubule
injury. It may not be the proteinuna per Se, but rather some-
thing which can accompany the proteinuria in some renal
diseases that is responsible for the tubulo-interstitial injury.
One potential toxin that accompanies proteinuria is the
transition element iron. Iron is presented to the tubular lumen in
proteinuric states because of the glomerular leak for transferrin.
At the pH of the tubule fluid, it seems likely that iron would be
released from transferrin. Because of iron's ability to accept
and donate electrons, it can catalyze the Haber-Weiss reaction
promoting the formation of hydroxyl radicals [15]. The hy-
droxyl radicals are highly reactive and can destroy almost all
known biomolecules [15] causing the tubulo-interstitial injury.
This study was undertaken to determine if iron could be
involved in the pathogenesis of tubulo-interstitial disease result-
ing from glomerular injury. Since urinary iron excretion in
glomerular disease is determined by the amount of glomerular
transferrin leak and the iron saturation of transferrin, nephro-
toxic serum nephritis was established in animals previously iron
depleted to minimize tubule fluid iron.
Methods
Nephrotoxic serum nephritis was produced in 21 uninephrec-
tomized male Sprague-Dawley rats by previously described
techniques [2, 16]. Two months prior to nephrectomy and
induction of nephrotoxic serum nephritis, the animals were
placed on normal rat chow (AIN-76, ICN, Costa Mesa, Cali-
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fornia, USA, containing either 45 or 8 mg/kg iron). Iron
deficiency was induced in eleven animals on the low iron diet by
drawing 2 ml of blood weekly over the two month period prior
to receiving nephrotoxic serum. After receiving the nephrotoxic
serum, the blood drawing to induce iron deficiency was discon-
tinued.
The rats were placed in Nalgene metabolic cages to collect
24-hour urine specimens for iron and protein determinations.
For blood determinations, serial samples were obtained from
the tail artery. The kidneys removed prior to induction of NSN
were saved for iron determination to be compared with the
kidney iron content at the termination of the study.
Analytical procedures
Protein and creatinine were measured with previously de-
scribed methods [2, 161. Urine, serum, and tissue iron were
determined with a flameless atomic absorption technique which
has a detection limit of 1 xg/1iter. A nitric acid digest was
carried out for tissue iron determinations. Serum and urine
transferrin measurements were performed with a nephelometric
method.
Kidney dry and wet weight were determined to calculate
water content.
Systolic blood pressure measurements were made in awake
animals using a rat tail blood pressure cuff.
Routine histology was performed on all kidneys and electron
microscopy on selected kidneys from both the control and iron
deficient group. Kidney tissue was prepared for light micros-
copy by fixing overnight in 4% buffered formaldehyde and
embedding in paraffin. Sections (3 j. thick) were stained with
hematoxylin-eosin, periodic acid-Schiff and trichrome. For
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Fig. 2. Daily urinary iron excretion at three times following nephro-
toxic serum. At each time, urinary iron was significantly less in the low
iron group (P < 0.001). Fe represents low iron diet and Fe represents
normal iron diet.
electron microscopy immersion fixation was carried out with
4% glutaraldehyde with a cacodylate buffer, pH 7.4. Electron
microscopic studies were otherwise performed by standard
techniques. Immunofluorescence studies for the detection of
IgG and complement were also carried out. Histological grading
of tubulo-interstitial and glomerular disease was made by one of
the authors (W.S.H.) in a blinded fashion.
Paired and unpaired Student's i-test were used to compare
results within and between groups, respectively. The Wilcoxon
signed ranks test was used for analysis of non-parametric data.
All results are expressed as mean 1 SEM.
Results
At the initiation of the study body weight was 351 7 in the
control animals vs. 325 15 g in the iron deficient group (P =
NS). However, during the course of NSN weight gain was less
in the iron deficient group (13 4 vs. 25 3 g, P < 0.05). The
initial hematocrit was 47 1 vs. 34 1% and serum iron 160
22 vs. 37 4 sgJdl in the control and iron deficient group,
respectively (P < 0.001). At the termination of the study, the
hematocrit was 39 1 vs. 34 1% and serum iron 115 13 vs.
28 3 jxg/dl in the respective groups.
Urine protein in the heterologous phase (1 day following
nephrotoxic serum) was 44 8.5 mg/day in the control group
and 44 7 mg/day in the iron deficient group (P = NS).
Similarly in the autologous phase (28 days following nephro-
toxic serum), urine protein was not significantly different be-
tween groups, 478 58 vs. 414 50 mg/day (Fig. 1).
Daily urinary iron excretion was measured at three times
during the study (Fig. 2). Urinary iron excretion was relatively
constant in both groups being significantly lower on each
occasion in the low iron group (P < 0.001). Urinary and serum
transferrin and iron were determined at the last collection
period in the control group to determine their respective ratios.
The iron/transferrin ratio was 1.12 0.14 in the urine as
compared to 0.55 0.06 g Fe/mg transferrin in the serum (P <
0.001).
At day 15 and 29 of the study, plasma creatinine was similar
in both groups. However, by day 50, it was significantly higher
in the control group and this difference was magnified by day 58
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Fig. 1. Urinary protein excretion in the heterologous (day 1) and
autologous phases of nephrotoxic serum nephritis (day 28). There was
no significant difference between groups in either period. Fe repre-
sents low iron group and Fe represents normal iron group.
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(Fig. 3; P < 0.001). Similarly creatinine clearance was un-
changed between day 30 (0.24 0.02) and day 58 (0.22 0.02
ml/l00 g body wt, P = NS) in the low iron group, in contrast to
the control group where there was a significant decrease in
creatinine clearance during this period (0.23 0.02 vs. 0.15
0.01 mIIlOO g body wt, P < 0.01).
Systolic blood pressure measurements obtained between day
50 and 58, at a time when there was progressive functional
deterioration, was 114 5 in the control animals and 108 8
mm Hg in the iron deficient group (P = NS).
At the termination of the study, single kidney weight was 5.14
0.82 in the controls versus 2.22 0.24 grams in the iron
Fig. 5. Light microscopic features of a kidney
obtained from an animal maintained on a
normal iron diet. There is extensive tubulo-
interstitial disease and mild sclerosis of the
glomeruli. The kidney weighted 5.17 grams
and was graded as 3 + tubulo-interstitial
disease.
deficient rats (normal uninephrectomized animal kidney 1.8
0.08 g). As found by other investigators [17, 181 the autologous
phase of NSN in the rat is usually a model of membranous
nephritis. Although basement membrane thickening was not
obvious on light microscopy, electron microscopy revealed
numerous subepithelial deposits with effacement of epithelial
foot processes (Fig. 4). Immunofluorescence showed a granular
deposit of IgG and complement. In the protected animals this
histological pattern of only membranous nephritis persisted
throughout the course of the disease. In contrast in the non-
protected animals extensive tubulo-interstitial disease occurred
with a variable amount of sclerosis of the glomeruli (Fig. 5).
Fig. 3. Plasma creatinine levels following nephrotoxic serum. Values
were similar in both groups at day 15 and 29. At day 50, (P < 0.05) and
day 58 (P < 0.01), values were significantly higher in the normal iron
group. Open circles represent low iron diet and closed circles represent
normal iron diet.
Fig. 4. Electron micrograph of a glomerulus obtained from an animal
in the low iron diet group at the termination of the study (day 59). There
are numerous subepithelial deposits with effacement of epithelial foot
processes but no leukocytic infiltration or inflammatory features (X
14,000).
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Percent focal and global sclerosis, as determined by counting
a minimum of 100 glomeruli in each kidney, was 56 7 in the
control animals versus 29 5% in the iron deficient animals (P
< 0.01). Histological grading of tubulo-interstitial disease was
2.45 0.39 in the controls versus 0.77 0.29 in the iron
deficient group (P < 0.01).
There was a highly significant correlation between the histo-
logical index of severity of tubulo-interstitial disease and kidney
weight (Fig. 6). There was also a very good correlation between
kidney weight and renal function as determined by the final
plasma creatinine (r = 0.94; Fig. 7). In contrast there was no
correlation between percent sclerotic glomeruli and renal func-
tion (r = 0.34).
There was also a significant correlation between kidney
weight and percent water content in both groups of animals (r=
0.85, P < 0.001). The kidney water content in the control group
was 82.9 0.9% as opposed to 79.5 0.6% in the low iron
group (P < 0.001). This represents a mean kidney water content
of 4.26 0.68 ml in the control group versus 1.76 0.19 in the
low iron group.
A highly significant correlation was found between urine iron
excretion and kidney weight for both groups (r = 0.815, P <
0.001) (Fig. 8). In the low iron group alone, there was also a
good correlation between urine iron excretion and kidney
weight (r = 0.789, P < 0.01; Fig. 9).
In contrast, there was no correlation between plasma iron,
and the correlation between urine protein and kidney weight
was much weaker than that found for urine iron (r = 0.565).
Following nephrotoxic serum, the kidney iron concentration
increased in the control group (195 9 vs. 486 36 mg/kg, P <
0.001) and correlated with kidney weight (r = 0.846, P < 0.01).
In contrast in the low iron group, kidney iron concentration was
higher at the beginning of the study (104 3 mg/kg) than at its
termination (84 3 mg/kg, P < 0.005) and there was no
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Fig. 6. Correlation between kidney weight
and histological index of tubulo-intcrstitial
—I disease. Open circles represent animals
+ + + + maintained on the low iron diet and closed
circles animals maintained on a normal iron
diet.
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Fig. 7. There was a significant correlation between kidney weight and
plasma creatinine. Open circles represent animals on a low iron diet
and closed circles represent animals on a normal iron diet.
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Fig. 8. There was a significant correlation between urinary iron excre-
tion and kidney weight. Open circles represent animals on a low iron
diet and closed circles represent animals on a regular iron diet (r =
0.815, P < 0.001).
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correlation between kidney iron concentration and kidney
weight.
Discussion
There recently has been increasing interest in the role of iron
and free radicals in the causation of renal injury in various
experimental models of renal disease [19, 20]. However, in
regards to models of chronic renal disease, studies have been
carried out early in the course and have been directed only at
the glomerular disease [21—23]. Boyce and Holdsworth found
that deferoxamine prevented the development of the heterolo-
gous phase proteinuria in nephrotoxic serum nephritis [23].
Similarly, Rehan et al found that catalase, presumably by
accelerating H202 breakdown, decreased the heterologous
phase proteinuria but had no effect on the autologous phase
proteinuria [21, 22]. In the present study, iron depletion had no
effect on either the heterologous phase or autologous phase
proteinuria. In addition, the amount of proteinuria in the
autologous phase of this disease was equal to or actually greater
than most other investigators have reported, suggesting that
iron depletion did not effect the glomerular disease resulting
from nephrotoxic serum. However, iron depletion had a major
effect on tubulo-interstitial disease.
It has been well established that extensive tubulo-interstitial
disease develops in this model in association with renal func-
tional deterioration and marked enlargement of the kidney [2,
16, 171. This is again supported in the present study. Further-
more, there was no correlation with glomerular disease, either
membranous glomerulonephritis which initially occurred and
persisted in the protected animals or focal and global sclerosis
which occurred late in the unprotected animals, and renal
function.
Although there was an excellent correlation between the
histological grading of tubulo-interstitial disease and kidney
weight, we elected to correlate kidney weight with other
features since its measurement is somewhat more precise. The
majority of increase kidney weight with disease is the result of
increase water representing interstitial edema and increase
tubule fluid present in the dilated and distended tubules. In
addition, as stated above there was also a highly significant
correlation between kidney weight and renal function.
These studii s strongly suggest that tubule fluid iron is respon-
sible for the tubulo-interstitial disease in nephrotoxic serum
nephritis. Not only was there a significant difference in func-
tional and anatomical changes between the iron deficient and
control group, there was also an excellent correlation between
tubulo-interstitial disease, as determined by histological grad-
ing, kidney weight and renal function and urinary iron excre-
tion. More importantly, this correlation was present when
either the iron deficient group or control group was evaluated
independently. In addition, besides the correlation between
urine iron and kidney weight in these groups, when urine iron
excretion overlapped between groups, kidney weight and renal
function also overlapped. Although the diets were identical with
the exception of iron, these latter findings exclude other varia-
bles which might have existed between groups. In further
support of tubule fluid iron being important in production of
disease rather than intrarenal or systemic iron is that disease
occurred in the low iron group in association with low plasma
iron levels and actually a fall in kidney iron concentration. This
would further suggest that kidney iron concentration in the
control group did not increase because of tubule fluid iron
content but rather it resulted from other mechanisms. Irrespec-
tive of why kidney iron is increased in the control animals, such
an increase in iron is obviously not required for the production
of tubulo-interstitial disease and renal failure.
Although anemia has been shown to be protective in the
remnant kidney model, at least, in regards to glomerular dis-
ease, this does not seem to be relevant in this model [6]. First,
as stated above, anemic animals also developed tubulo-intersti-
tial disease. Secondly, it was felt that anemia was protective in
the remnant kidney model by reducing systemic blood pressure.
In contrast, in this model, where blood pressure is not elevated,
anemia had no effect on blood pressure. Finally, in contrast to
the remnant kidney model where anemia prevented glomerular
disease as determined by reduction of proteinuria, in this
model, neither anemia nor iron deficiency-effected proteinuria.
Normally, iron enters the renal tubule cells from the basolat-
eral side with transferrmn, via its receptor, and is deposited in a
non-toxic form with ferritin [24]. In contrast, because of the
protein leak in glomerular disease, iron (in association with
transferrin) enters the tubule lumen. Since it is unlikely that
there are transferrin receptors on the luminal surface of the
tubule cell, the iron transferrmn complex could be taken up by
endocytosis, as occurs for other proteins [25]. In addition, iron
tends to dissociate from transferrin at a pH of less than 7 and is
almost completely dissociated at a pH of less than 6.5 [26].
Proximal tubule pH is approximately 6.5 and bicarbonate
content can be as low as 8 mmol, and pH and bicarbonate is
even lower in other areas of the nephron [27]. This dissociation
could be enhanced by the presence of chelators such as citrate
in the tubule fluid. The finding that iron/transferrin ratio was
twice as high in urine as serum is strong evidence that iron and
.
.
.
.
4
>.
C
2
0
Urine iron, pg/day
Fig. 9. Low iron group evaluated alone also demonstrate a sign/1cant
correlation between urina,y iron excretion and kidney weight (r =
0.789, P <0.01).
1 2 3 4 5 6 7 8 9 10
758 Alfrey et a!: Role of iron in NSN
transferrin are indeed dissociated and handled differently by the
renal tubule. The fact that in a number of urines the ratios were
greater than 1.2 jsg Fe/mg transferrin would mean there was not
enough transferrin to bind all of the iron present even if both
sites on transferrin were occupied. Although this finding does
not prove the presence of free iron capable of catalyzing
Haber-Wiess reaction it would be consistent with this possibil-
ity. Furthermore, these studies have not documented that lipid
peroxidation was occurring.
There is additional direct evidence for the renal tubule
toxicity of intraluminal iron from studies using ferric nitrilotri-
acetate [28, 29]. Ferric nitrilotriacetate is a chelate of iron of
low molecular weight which would be readily filtered by the
glomerulus. This compound has repeatedly been shown to
cause anatomic and functional changes in the proximal tubule
which is thought to be the result of free radical formation and
lipid peroxidation [28, 291. Although these studies have been
concerned with acute renal injury it seems possible with more
prolonged exposure, chronic disease might also occur.
It is well recognized that not all forms of proteinuric renal
disease develop extensive tubulo-interstitial disease and renal
failure. This could result from variations in tubular fluid iron
exposure, since these studies show that the rate of progression
of renal failure is directly related to the amount and duration of
tubule exposure to iron. Thus, the status of the body iron
burden and size and duration of the glomerular protein leak
might be major determinates of the rate of renal functional
deterioration. In addition, because of difference in size and
configuration of transferrin and albumin, the relative clearance
of these protein could vary with different glomerular diseases
[26]. Unfortunately, there have been but a limited number of
studies evaluating urinary iron and transferrin excretion, and
the results are somewhat conflicting [30—35].
In summary, these studies are consistent with the hypothesis
that tubule fluid iron is responsible for the tubulo-interstitial
disease present in nephrotoxic serum nephritis. Until now, all
methods of preventing progression of renal failure have been
directed at the glomerulus. However, these studies suggest that
means may subsequently be found to prevent the tubulo-
interstitial disease and functional deterioration that occurs as a
consequence of the glomerular disease.
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